Earlier this month, Ohio Gov. Mike DeWine received a false-positive result from a rapid antigen test for Covid-19, raising concerns about the tests' accuracy. The assay's maker, Quidel, said it is investigating the case.
Ohio University spinoff Diagnostic Hybrids Inc. has received Chinese regulatory approval to sell a respiratory virus testing kit. The company’s D3 Ultra DFA Respiratory Virus Screening and ID Kit screens and identifies the following viruses: Influenza A, Influenza B, Parainfluenza 1, 2 and 3, Respiratory Syncytial Virus and Adenovirus. The test is capable of returning […]
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
Akron now has a biomedical district, according to the Akron Beacon Journal. With a few minor changes, city council approved legislation Monday that outlined the district — changing it from concept to reality — and made several zoning changes within the area that encompasses the city's three downtown hospitals and the University of Akron.
San Diego diagnostic test maker Quidel Corp. has closed its acquisition of Diagnostic Hybrids Inc. for about $130 million in cash. Announced in mid-January, the acquisition is expected to add depth and innovation to Quidel's line of rapid, point-of-care tests for pregnancy, infectious diseases, cancer, bone health and autoimmune disorders.
A sale of Youngstown's Forum Health, which is reorganizing under Chapter 11 bankruptcy protection, to Nashville, Tenn., hospital system Ardent Health Services hinges on successful negotiations with unions representing about 3,500 Forum workers, unnamed sources told the Tribune Chronicle.
San Diego diagnostic test maker Quidel Corp. plans to buy Diagnostic Hybrids Inc. in Athens, Ohio, a more sophisticated diagnostic test maker, for $130 million in cash.
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.